Acadia Pharmaceuticals reported $5.84M in Stock for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Acadia Pharmaceuticals ACAD:US USD 5.84M 483K
ALKERMES ALKS:US USD 166.3M 10.69M
Alnylam Pharmaceuticals ALNY:US USD 115.49M 26.51M
Biogen BIIB:US USD 1.38B 80.8M
Biomarin Pharmaceutical BMRN:US USD 839.46M 37.14M
Bristol Myers Squibb BMY:US USD 2.07B 68M
Cara Therapeutics CARA:US USD 1.84M 1.62M
Corcept Therapeutics CORT:US USD 17.07M 342K
Eisai 4523:JP JPY 114.41B 10.9B
Eli Lilly And LLY:US USD 3.83B 68.3M
Intra Cellular Therapies ITCI:US USD 23.6M 1.42M
Johnson & Johnson JNJ:US USD 11.68B 238M
Moderna Inc MRNA:US USD 2.08B 156M
Neurocrine Biosciences NBIX:US USD 37M 7.7M
Ptc Therapeutics PTCT:US USD 14.81M 192K
Sarepta Therapeutics SRPT:US USD 221.19M 13.1M
Seattle Genetics SGEN:US USD 364.97M 45.62M
Ultragenyx Pharmaceutical RARE:US USD 21.85M 770K
Vanda Pharmaceuticals VNDA:US USD 1.59M 94K
Vertex Pharmaceuticals VRTX:US USD 388.2M 20.5M
YTE INCY:US USD 45.87M 8.63M